Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

ABCL

AbCellera Biologics Inc.

CIK 0001703057 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$11.32
↓ 0.25 (-2.16%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BullishOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Technicals, Options; Risks: Fundamentals

Key stats

Market Cap
$3.47B
P/E Ratio
-21.08
EPS
-0.49
Dividend Yield
Not covered
52W Position
91%
Beta
2.60

Valuation multiples

Fwd P/E
27.55
PEG
Not covered
P/B
3.87
P/S
52.45
EV/Revenue
50.64
ROE
-18.4%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 91%
$2.75$12.15

Latest Financials

2025-12-31 FY
Revenue
$75.13M
Net Income
-$146.41M
Total Assets
$1.36B
Free Cash Flow
-$174.07M

Recent news